Drug guidance
Metformin extended release for treating type 2 diabetes mellitus
Condition
Endocrine and metabolic
18 January 2021
Published on 18 Jan 2021
Last Updated on 18 Jan 2021
Guidance Recommendations
The Ministry of Health’s Drug Advisory Committee has not recommended listing metformin extended release on the Standard Drug List (SDL) for treating type 2 diabetes mellitus because of limited clinical need and unfavourable cost-effectiveness compared with metformin immediate release.
Metformin extended release for treating type 2 diabetes mellitus (18 Jan 2021) [PDF, 44 KB]